Skip to main content
OpenTrials
Completed

NCT Number: NCT06296238

Nutrition and Inflammation in Pregnancy: Impacts on Early Human Brain Development in Ethiopia

The goal of this observational child follow-up study is to examine the effects of prenatal nutrition and infection management interventions on long-term child neurodevelopment.

Participants are the offspring of mothers in the main study entitled "Enhancing Nutrition and Antenatal Infection Treatment (ENAT)" that was conducted in the rural Amhara region of Ethiopia. In the ENAT pragmatic clinical effectiveness study, 2399 pregnant women were randomized to receive routine prenatal care, a package of enhanced nutrition interventions (balanced energy protein supplement, iodized salt, iron-folic acid and counseling), a package of enhanced infection management interventions (genitourinary tract infection screening-treatment, deworming), or a combination of both packages. The impact of these antenatal nutrition and infection interventions on birth outcomes (infant birth size and gestational length) was examined in the main study. In this longitudinal cohort study, we will follow the offspring from the ENAT pregnancy cohort up to 24 months postnatal age and assess their growth, health and neurodevelopment.

The main questions it aims to answer are:

1. What are the effects of pregnancy interventions from the parent study (ENAT) on offspring neurodevelopmental outcomes? 2. What are the associations between maternal-newborn iron status and inflammation on infant neurodevelopment? 3. What are the associations between maternal iodine status and thyroid function on infant neurodevelopment?

We will follow children of mothers from the parent ENAT study to monitor their growth, health, and neurodevelopment up to 24 months postnatal age.

Completed

Looking for future studies?

Notify Me

Key information

Age range

9 month–27 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Health Centers in West Gojjam and South Gondar zones

Bahir Dar, Amhara, Ethiopia

About this study

In low-resource settings, undernutrition and infections during the first 1000 days of life are prevalent, modifiable risk factors that may have lifelong effects on a child's cognitive and psychological development, yet effective interventions addressing prevailing mechanisms are still to be validated. Iron, protein and energy are critical nutrients that support the rapidly developing fetal brain, however, among women of reproductive age in Sub-Saharan Africa, 10% are underweight and 20% have iron deficiency anemia. Pregnancy infections are also common in Africa, where one in three women have a geo-helminthic infection resulting in blood loss, iron deficiency and inflammation. The interaction between iron and inflammation in pregnancy is particularly complex. NICHD has identified the complex relationship between nutrition, inflammation, and neurodevelopment as a major research gap. A barrier to progress is that mechanistic understanding of prenatal brain development is based on animal or observational studies. We present a unique opportunity to leverage an ongoing randomized controlled trial (RCT) to examine the consequences of pregnancy nutrition and inflammation on child neurodevelopment.

The Enhancing Nutrition and Antenatal Infection Treatment (ENAT) RCT enrolled pregnant women in Amhara, Ethiopia to study independent and overlapping effects of prenatal nutrition and infection interventions on birth outcomes. Women were randomized to receive: 1) standard prenatal care, 2) enhanced nutrition package (ENP) (counseling, iron-folic acid [IFA], iodized salt, and balanced energy protein [BEP] supplementation), 3) enhanced infection management package (EIMP) (anti-helminthics, urinary tract infection treatment), or 4) ENP+EIMP. The current follow-up study (Longitudinal Infant Development and Growth; LIDG) will investigate biological pathways by which ENAT interventions, specifically iron, protein-energy, and inflammation, influence child neurodevelopment.

Our overarching hypotheses are that improving prenatal nutrition will improve brain structural and network development, reducing inflammation will improve white matter maturation, and the combination will have synergistic effects on child neuro-cognitive outcomes. This study will follow up to 500 ENAT children to assess neurodevelopment through 24 months of age, including neurobehavior and neural networks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mothers who have participated in ENAT study who consent to participate in the infant follow up study
  • Intention to stay in the study catchment area
  • Healthy infants without severe clinical signs or symptoms including headache, vomiting, or dizziness

Exclusion criteria

  • Major congenital anomalies
  • Infants with severe morbidity or developmental disorder
  • Neonatal encephalopathy
  • Plan to move out of study catchment area

Treatment and study plan

Primary outcomes

  1. Child resting brain function

    Time frame: 24 months

    Measured by absolute power of alpha frequency band on mobile electroencephalography

Secondary outcomes

  1. Child resting brain function, secondary measures

    Time frame: 24 months

    Absolute power of theta band (3-5 Hz) as measured on mobile EEG

  2. Neural processing speed

    Time frame: 24 months

    VEP P1 peak latency (ms)

  3. Visual Attention

    Time frame: 12 months

    Measured with infant eye tracking during Cecile Attention Task

  4. Nonverbal Visual Attention

    Time frame: 12 months

    Multisensory Attention Assessment Protocol

  5. Infant Neurologic Maturity

    Time frame: 12 months

    Hammersmith Infant Neurological Exam (HINE) Total Score

  6. Child Cognitive Function

    Time frame: 24 months

    Bayley-III Cognitive Scale

  7. Child size

    Time frame: 24 months

    Length for age Z score [standard deviations from the median for age and sex, range: -5 (worse) to +5 (better)]

  8. Child Size

    Time frame: 24 months

    Weight for age z score [standard deviations from the median for age and sex, range: -5 (worse) to +5 (better)]

  9. Child Size

    Time frame: 24 months

    Head circumference for age z score [standard deviations from the median for age and sex, range: -5 (worse) to +5 (better)]

  10. Child Size

    Time frame: 24 months

    Body mass index

  11. Brain Structure

    Time frame: 12 months

    Total brain volume (cm3); regional volumes measure by hyperfine low field MRI

  12. Child Morbidity

    Time frame: 12 and 24 months

    Fever, diarrhea, hospitalization

Other outcomes

  1. Resting Brain Function

    Time frame: 24 months

    Relative power of alpha, theta, beta, gamma bands

  2. Functional brain connectivity

    Time frame: 24 months

    Neural network efficiency and organization across brain regions measured on EEG

Sponsors and collaborators

Lead sponsor

Brown University

Other

Collaborators

  • Addis Continental Institute of Public Health
  • Boston Children's Hospital
  • Brigham and Women's Hospital
  • Johns Hopkins University
  • New York University

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Mar 6, 2024
Registry last updated
Jun 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.